Aufbau Holdings

About:

Aufbau Holdings is Identifying new disease targets and developing novel therapeutics for treating vision-threatening eye diseases.

Website: https://www.aufbauholdings.com/home

Description:

Aufbau Holdings is Identifying new disease targets and developing novel therapeutics for treating vision-threatening eye diseases. The company conducts research and development for novel diagnostic and therapeutic platform technologies for the detection, monitoring, and treatment of ophthalmic disorders and life-threatening systemic cancers. Aufbau Holdings was founded in 2019 and is headquartered in Dublin, Ireland.

Total Funding Amount:

$6.54M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Dublin, Dublin, Ireland

Founded Date:

2019-01-01

Founders:

John Pena

Number of Employees:

Last Funding Date:

2023-11-15

IPO Status:

Private

Industries:

© 2025 bioDAO.ai